Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
STAAR SURGICAL CO | 10%+ Owner | Common Stock | 13.5M | $205M | $15.18 | Apr 10, 2025 | Direct |
STAAR SURGICAL CO | 10%+ Owner | Common Stock | 13.5M | $205M | $15.18 | Apr 10, 2025 | Indirect |
Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Shares | 49.6M | $37.7M | $0.76 | Jan 27, 2025 | Direct |
Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Shares | 49.6M | $37.7M | $0.76 | Jan 27, 2025 | Indirect |
Oncocyte Corp | 10%+ Owner | Common Stock, no par value | 11.4M | $23.4M | $2.05 | Feb 6, 2025 | Direct |
Oncocyte Corp | 10%+ Owner | Common Stock, no par value | 11.4M | $23.4M | $2.05 | Feb 6, 2025 | Indirect |
Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Warrant | 7.89M | Jan 27, 2025 | Direct | ||
Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Warrant | 7.89M | Jan 27, 2025 | Indirect | ||
Oncocyte Corp | 10%+ Owner | Warrant to Purchase Common Stock | 150K | Feb 6, 2025 | Direct | ||
Oncocyte Corp | 10%+ Owner | Warrant to Purchase Common Stock | 150K | Feb 6, 2025 | Indirect | ||
Oncocyte Corp | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Apr 15, 2024 | Direct | ||
Oncocyte Corp | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Apr 15, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STAA | STAAR SURGICAL CO | Apr 8, 2025 | 8 | $2.87M | 4 | Apr 10, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Apr 3, 2025 | 10 | $13.6M | 4 | Apr 7, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Mar 31, 2025 | 4 | $941K | 4 | Apr 2, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Mar 26, 2025 | 6 | $1.98M | 4 | Mar 28, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Mar 21, 2025 | 4 | $2.41M | 4 | Mar 25, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Mar 18, 2025 | 6 | $3.59M | 4 | Mar 20, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Mar 4, 2025 | 4 | $482K | 4 | Mar 6, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Feb 27, 2025 | 12 | $11.3M | 4 | Mar 3, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Feb 12, 2025 | 10 | $6.27M | 4 | Feb 14, 2025 | 10%+ Owner |
OCX | Oncocyte Corp | Feb 6, 2025 | 4 | $10.6M | 4 | Feb 10, 2025 | 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Jan 27, 2025 | 4 | $6M | 4 | Jan 28, 2025 | Director, 10%+ Owner |
STAA | STAAR SURGICAL CO | Jan 14, 2025 | 4 | $631K | 4 | Jan 16, 2025 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Dec 16, 2024 | 8 | $1.95M | 4 | Dec 18, 2024 | 10%+ Owner |
OCX | Oncocyte Corp | Oct 2, 2024 | 2 | $3.88M | 4 | Oct 4, 2024 | 10%+ Owner |
STAA | STAAR SURGICAL CO | May 9, 2024 | 2 | $42.60 | 4 | May 13, 2024 | 10%+ Owner |
OCX | Oncocyte Corp | Apr 11, 2024 | 4 | $7.06M | 4 | Apr 15, 2024 | 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Feb 6, 2024 | 2 | $7M | 4 | Feb 8, 2024 | Director, 10%+ Owner |
STAA | STAAR SURGICAL CO | Jan 8, 2024 | 2 | $110K | 4 | Jan 10, 2024 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Jan 3, 2024 | 8 | $6.48M | 4 | Jan 5, 2024 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Nov 28, 2023 | 10 | $13.7M | 4 | Nov 30, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Nov 10, 2023 | 4 | $1.14M | 4 | Nov 14, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Nov 7, 2023 | 8 | $9.66M | 4 | Nov 9, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Nov 2, 2023 | 8 | $10.8M | 4 | Nov 6, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Oct 4, 2023 | 6 | $7.76M | 4 | Oct 6, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Sep 19, 2023 | 6 | $11.7M | 4 | Sep 21, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Sep 5, 2023 | 6 | $7.87M | 4 | Sep 7, 2023 | 10%+ Owner |
OCX | Oncocyte Corp | Apr 3, 2023 | 2 | $8.09M | 4 | Apr 5, 2023 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Dec 27, 2022 | 6 | $9.06M | 4 | Dec 29, 2022 | 10%+ Owner |
OCX | Oncocyte Corp | Apr 13, 2022 | 6 | $8M | 4 | Apr 15, 2022 | 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Mar 23, 2022 | 6 | $1.32M | 4 | Mar 25, 2022 | Director, 10%+ Owner |
STAA | STAAR SURGICAL CO | Oct 1, 2021 | 2 | $0 | 4 | Oct 1, 2021 | 10%+ Owner |
OCX | Oncocyte Corp | Sep 23, 2021 | 8 | $1.81M | 4 | Sep 24, 2021 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Jul 1, 2021 | 2 | $0 | 4 | Jul 2, 2021 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Jun 24, 2021 | 6 | -$35.7M | 4 | Jun 28, 2021 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Jun 16, 2021 | 6 | -$16.2M | 4 | Jun 21, 2021 | 10%+ Owner |
STAA | STAAR SURGICAL CO | Jun 11, 2021 | 6 | -$8.79M | 4 | Jun 15, 2021 | 10%+ Owner |
STAA | STAAR SURGICAL CO | May 27, 2021 | 6 | -$39.1M | 4 | Jun 1, 2021 | 10%+ Owner |